These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2209216)

  • 21. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
    Xing S; Wu Y; Liu J; Xu R; Zhang Z; Wang Y
    Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary calcium and bone turnover markers].
    de la Torre Vega JP; Amador Licona N; Zamora Mata L; Morales Ramos Ael J
    Ginecol Obstet Mex; 2004 Jan; 72(1):23-8. PubMed ID: 15239561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
    Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T
    Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: creatinine ratios.
    Kaplan B; Neri A; Kitai E; Pardo Y; Blum M; Friedman J
    Clin Exp Obstet Gynecol; 1994; 21(3):170-2. PubMed ID: 7923797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of a "conventional" estro-progestinic drug at low dosage in premenopausal and menopausal women].
    Berghella A
    Minerva Ginecol; 1976 May; 28(5):456-7. PubMed ID: 1018827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women.
    Jensen J; Christiansen C; Rødbro P
    Maturitas; 1986 Oct; 8(3):209-16. PubMed ID: 3784917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinical study on memory function in climacteric and periclimacteric women].
    Ohkura T; Isse K; Watabe H; Segawa Y; Mitsuya K; Enomoto H; Hayashi M; Yaoi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):271-6. PubMed ID: 8133139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(6 Pt 1):589-600. PubMed ID: 15545786
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of late night calcium supplements on overnight urinary calcium excretion in premenopausal and postmenopausal women.
    Belchetz PE; Lloyd MH; Johns RG; Cohen RD
    Br Med J; 1973 Jun; 2(5865):510-2. PubMed ID: 4714465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sequential method of administration of gestagens in the treatment of climateric syndrome].
    Potocki J; Teter J; Ladygin E; Krawczyk D; Jedrzejewski M
    Ginekol Pol; 1969 Jan; 40(1):63-6. PubMed ID: 5780813
    [No Abstract]   [Full Text] [Related]  

  • 37. Microheterogeneity of alpha 1-acid glycoprotein: variation during the menstrual cycle in healthy women, and profile in women receiving estrogen-progestogen treatment.
    Succari M; Foglietti MJ; Percheron F
    Clin Chim Acta; 1990 Mar; 187(3):235-41. PubMed ID: 2323063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postmenopausal hyperestrogenuria (natural and surgical menopause)].
    KLOTZ HP; JAYLE MF
    Ann Endocrinol (Paris); 1951; 12(5):931-7. PubMed ID: 14903665
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogen excretion levels in the normal postmenopausal woman.
    McBRIDE JM
    J Clin Endocrinol Metab; 1957 Dec; 17(12):1440-7. PubMed ID: 13481089
    [No Abstract]   [Full Text] [Related]  

  • 40. [Total urinary estrogen excretion in women with glaucoma simplex at the time of climacteric].
    Gierek A; Samochowiec E
    Ginekol Pol; 1973 Oct; 44(10):1163-9. PubMed ID: 4765779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.